Additionally, ANXA5 is significantly expressed in non-papillary bladder cancer (Wu et al., 2021), and lung cancer patients with high Cir–ANXA seven expression tend to have a poorer prognosis (Wang, 2021). Here, ANXA5 is linked to lung carcinoma.